威尔药业
(603351)
| 流通市值：36.24亿 | | | 总市值：36.24亿 |
| 流通股本：1.35亿 | | | 总股本：1.35亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 356,303,724.13 | 1,335,037,035.4 | 1,018,241,707.95 | 673,722,955.67 |
| 营业收入 | 356,303,724.13 | 1,335,037,035.4 | 1,018,241,707.95 | 673,722,955.67 |
| 二、营业总成本 | 313,328,245.76 | 1,170,622,101.96 | 892,228,158.27 | 588,979,381.47 |
| 营业成本 | 258,375,425.47 | 955,039,689.35 | 728,251,744.26 | 484,557,044.44 |
| 税金及附加 | 2,337,521.51 | 8,655,170.58 | 6,602,047.19 | 4,373,876.45 |
| 销售费用 | 3,341,443.74 | 16,865,139.75 | 13,273,755.93 | 7,317,179.47 |
| 管理费用 | 24,384,580.6 | 97,034,374.5 | 75,185,518.31 | 48,425,467.75 |
| 研发费用 | 19,093,875.62 | 81,530,712.66 | 60,977,699.68 | 38,837,337.11 |
| 财务费用 | 5,795,398.82 | 11,497,015.12 | 7,937,392.9 | 5,468,476.25 |
| 其中:利息费用 | 3,848,448.22 | 10,681,231.9 | 8,022,178.25 | 5,955,785.21 |
| 其中:利息收入 | 113,836.77 | 504,607.31 | 428,666.71 | 176,372.05 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | - | 3,413,109.64 | 4,240,786.22 | 1,736.22 |
| 加:投资收益 | - | 24,989.15 | 15,363.51 | - |
| 资产处置收益 | - | 16,250.03 | 16,250.03 | 6,484.57 |
| 资产减值损失(新) | - | -6,031,196.28 | -2,467,637.19 | -2,467,637.19 |
| 信用减值损失(新) | -880,076.57 | -362,660.43 | -264,721.58 | -449,956.84 |
| 其他收益 | 1,830,676.44 | 11,615,167.25 | 6,368,256.79 | 4,116,917.55 |
| 四、营业利润 | 43,926,078.24 | 173,090,592.8 | 133,921,847.46 | 85,951,118.51 |
| 减:营业外支出 | 3,681.92 | 445,699.85 | 342,331.89 | 94,473.02 |
| 五、利润总额 | 43,922,396.32 | 172,644,892.95 | 133,579,515.57 | 85,856,645.49 |
| 减:所得税费用 | 7,074,399 | 23,657,821.65 | 21,840,816.08 | 14,554,015.03 |
| 六、净利润 | 36,847,997.32 | 148,987,071.3 | 111,738,699.49 | 71,302,630.46 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 36,847,997.32 | 148,987,071.3 | 111,738,699.49 | 71,302,630.46 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 37,634,039.87 | 150,968,971.49 | 114,065,424.69 | 72,766,854.52 |
| 少数股东损益 | -786,042.55 | -1,981,900.19 | -2,326,725.2 | -1,464,224.06 |
| 扣除非经常损益后的净利润 | 37,630,489.98 | 145,849,212.35 | 110,469,598.95 | 72,248,911.49 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.28 | 1.11 | 0.84 | 0.54 |
| (二)稀释每股收益 | 0.28 | 1.11 | 0.84 | 0.54 |
| 九、综合收益总额 | 36,847,997.32 | 148,987,071.3 | 111,738,699.49 | 71,302,630.46 |
| 归属于母公司股东的综合收益总额 | 37,634,039.87 | 150,968,971.49 | 114,065,424.69 | 72,766,854.52 |
| 归属于少数股东的综合收益总额 | -786,042.55 | -1,981,900.19 | -2,326,725.2 | -1,464,224.06 |
| 公告日期 | 2026-04-28 | 2026-04-28 | 2025-10-30 | 2025-08-20 |
| 审计意见(境内) | | 标准无保留意见 | | |